Organ Transplantation Psychiatry

Organ Transplantation Psychiatry - Green Light Check

• Goal: Assess psychosocial suitability for transplant.
• Core Assessment Areas (📌 LAST: Lifestyle, Adherence, Support, Temperament):
  • Mental status, cognitive function (consent capacity).
  • Psychiatric history (mood, psychosis, anxiety).
  • Substance use (>6 months abstinence vital, esp. alcohol/drugs).
  • Social support, coping skills.
  • Transplant understanding, adherence potential.
• Key Contraindications (Red Flags 🚩):
  • Active psychosis, severe unstable mood disorder.
  • Active substance abuse (failing >6 months abstinence).
  • Severe cognitive impairment precluding consent/adherence.
  • Persistent, documented non-adherence.
  • Critically inadequate social support.

⭐ Active substance dependence (especially ongoing alcohol or illicit drug use within the last 6 months) is a strong relative or absolute psychiatric contraindication to organ transplantation.

Organ Transplantation Psychiatry - Post-Op Mind Benders

• Common Acute Issues:
  • Delirium: Most frequent; fluctuating consciousness.
  • Anxiety/Agitation.
  • Psychosis: Can be drug-induced.
• Key Triggers:
  • Medications: Corticosteroids, Immunosuppressants (CNIs: Tacrolimus, Cyclosporine), Anesthesia.
  • Systemic: Infection, metabolic issues, pain, hypoxia.
  • ICU Environment.
• Drug Neurotoxicity Highlights:
  • Corticosteroids: Psychosis, mania, depression.
  • CNIs (Tacrolimus, Cyclosporine): Tremor, headache, seizures, PRES, delirium.
• Management Basics:
  • Identify & treat underlying medical cause (infection, metabolic).
  • Supportive care: Reorientation, sleep hygiene.
  • Pharmacological: Antipsychotics (Haloperidol); Benzodiazepines (cautious use).

⭐ Delirium is the most common psychiatric complication in the immediate peri-operative period, affecting up to 50% of some transplant populations (e.g., liver, lung).

Organ Transplantation Psychiatry - Meds & Mood Maze

• Immunosuppressant Neuropsychiatric Effects:
  • Corticosteroids: Mood (mania/depression), psychosis, anxiety, insomnia; dose-dependent.
  • CNIs (Tacrolimus, Cyclosporine): Anxiety, delirium, tremor, PRES.
  • mTOR Inhibitors (Sirolimus): Anxiety, depression.
• DDIs: CYP450 (esp. CYP3A4) crucial.
  • Inducers (Carbamazepine, St. John's Wort): ↓ levels → rejection.
  • Inhibitors (Fluoxetine, Valproate, Azoles, grapefruit): ↑ levels → toxicity.
  • 📌 St. John's Wort: AVOID (potent inducer).
• Psychotropic Management:
  • Monitor levels (immunosuppressants, Lithium).
  • SSRIs (e.g., Sertraline) preferred (fewer DDIs).
  • Caution: QTc prolonging drugs.

⭐ Corticosteroids (e.g., prednisolone) are well-known to cause a wide range of neuropsychiatric side effects, including mood changes (mania, depression), psychosis, anxiety, and insomnia, often dose-dependent.

oka

Organ Transplantation Psychiatry - Long Haul Psyche Care

• Key Focus Areas: Sustained mental well-being, medication adherence, Quality of Life (QoL).
• Common Long-Term Issues:
  • Depression & Anxiety: Persistent or recurrent; screen regularly.
  • PTSD: Related to transplant experience, ICU stay.
  • Body Image Concerns: Scars, weight changes (e.g., corticosteroids).
  • Neurocognitive Effects: Immunosuppressants (e.g., tacrolimus, cyclosporine) can impact memory/concentration.
  • Substance Use Relapse: Ongoing monitoring crucial.
  • Caregiver Burden: Significant stress on family; requires support.
• Medication Adherence: Paramount for graft survival.

  ⭐ Non-adherence to immunosuppressive medication regimens is a significant cause of late graft dysfunction and failure, with rates estimated between 20-50% at various times post-transplant.

• Interventions: Psychotherapy (CBT, supportive), psychopharmacology, peer support groups, psychoeducation for patient and family.

High‑Yield Points - ⚡ Biggest Takeaways

• Pre-transplant psychiatric evaluation is crucial for suitability, adherence potential, and psychosocial support.
• Common post-transplant: delirium, anxiety, depression, PTSD.
• Immunosuppressants (e.g., corticosteroids) can cause neuropsychiatric side effects (mood changes, psychosis).
• Substance use (especially alcohol) is a major contraindication and relapse risk.
• Adherence to medical regimen is paramount; psychiatric stability significantly impacts this.
• Capacity assessment is vital if psychiatric illness impacts transplant decision-making.